237 related articles for article (PubMed ID: 4314179)
21. "Early, non-virion" antigens in herpes simplex virus infected tissue culture cells. I. Detection of "early" antigens with complement fixation test.
Géder L; Váczi L; Gönczöl E; Jeney E; Lehel F
Acta Microbiol Acad Sci Hung; 1966-1967; 13(4):357-64. PubMed ID: 4292750
[No Abstract] [Full Text] [Related]
22. Immunochemical studies of foot-and-mouh disease. IX. Differences in neutralizing activities of guinea pig and bovine 19S and 7S antibodies.
Wagner GG; Cown KM
J Immunol; 1971 Mar; 106(3):656-60. PubMed ID: 4323129
[No Abstract] [Full Text] [Related]
23. Relation of type 2 Herpesvirus antibodies to cervical neoplasia. Barbados, West Indies, 1971.
Ory H; Conger B; Richart R; Barron B
Obstet Gynecol; 1974 Jun; 43(6):901-4. PubMed ID: 4364212
[No Abstract] [Full Text] [Related]
24. [Formation of antibody to nucleocapsid and envelope of Herpes simplex virus hominis].
Doerr HW; Schmitz H; Petersen EE
Zentralbl Bakteriol Orig A; 1974; 227(1-4):348-54. PubMed ID: 4154610
[No Abstract] [Full Text] [Related]
25. Complement-requiring neutralizing antibodies in hyperimmune sera to human cytomegaloviruses.
Graham BJ; Minamishima Y; Dresman GR; Haines HG; Benyesh-Melnick M
J Immunol; 1971 Dec; 107(6):1618-30. PubMed ID: 4330457
[No Abstract] [Full Text] [Related]
26. Neutralizing antibodies to herpesvirus types 1 and 2 in carcinoma of the cervix, carcinoma in situ and cervical dysplasia.
McDonald AD; Williams MC; Manfreda J; West R
Am J Epidemiol; 1974 Aug; 100(2):130-5. PubMed ID: 4368955
[No Abstract] [Full Text] [Related]
27. Estimation of specific antibody to type 2 Herpes simplex virus among patients with carcinoma of the uterine cervix.
Kawana T; Yoshino K; Kasamatsu T
Gan; 1974 Oct; 65(5):439-45. PubMed ID: 4373302
[No Abstract] [Full Text] [Related]
28. Further analysis of physiochemical and immunologic properties of herpes simplex vus precipitating antigens.
Tokumaru T
Arch Gesamte Virusforsch; 1970; 29(4):295-306. PubMed ID: 4315820
[No Abstract] [Full Text] [Related]
29. Antigens of Herpes simplex virus type 1 and 2-immunodiffusion and inhibition passive hemagglutination studies.
Schneweis KE; Nahmias AJ
Z Immunitatsforsch Exp Klin Immunol; 1971 Jun; 141(5):471-87. PubMed ID: 4326538
[No Abstract] [Full Text] [Related]
30. Herpes simplex virus antibody in south Indian patients with carcinoma cervix.
Seshadri L; Seth P; Walter A; Seshadri MS; John TJ
Indian J Med Res; 1984 Jan; 79():13-8. PubMed ID: 6327511
[No Abstract] [Full Text] [Related]
31. Comparison of antibody-dependent cellular cytotoxicity and complement-dependent antibody lysis of herpes simplex virus-infected cells as methods of detecting antiviral antibodies in human sera.
Subramanian T; Rawls WE
J Clin Microbiol; 1977 Jun; 5(6):551-8. PubMed ID: 195975
[TBL] [Abstract][Full Text] [Related]
32. Immunofluorescent studies on the reactivity of "early" and "late" herpes-immune rabbit sera with virus-induced antigenic formations of HEp-2 cells.
Géder L; Váczi L; Lehel F; Gönczöl E; Jeney E
Acta Microbiol Acad Sci Hung; 1970; 17(1):69-75. PubMed ID: 4319259
[No Abstract] [Full Text] [Related]
33. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. II. Uganda.
Adam E; Sharma SD; Zeigler O; Iwamoto K; Melnick JL; Levy AH; Rawls WE
J Natl Cancer Inst; 1972 Jan; 48(1):65-72. PubMed ID: 4347030
[No Abstract] [Full Text] [Related]
34. Antibodies to herpes simplex virus types 1 and 2: a comparative study using indirect haemagglutination in carcinoma of the cervix and in other malignant conditions.
Freymuth F; Morel C; Longson A; Tanguy M
Biomedicine; 1975 Sep; 23(7):271-5. PubMed ID: 182291
[TBL] [Abstract][Full Text] [Related]
35. A review of the identification and titration of antibodies to herpes simplex viruses type 1 and type 2 in human sera.
Plummer G
Cancer Res; 1973 Jun; 33(6):1469-76. PubMed ID: 4352384
[No Abstract] [Full Text] [Related]
36. [Oncogen infectious nucleoproteid from "statu nascendi" stages of cervical cancer and herpes virus hominis (author's transl)].
Eschbach W; Glathe H; Nöbel B
Arch Geschwulstforsch; 1974; 43(4):364-76. PubMed ID: 4372969
[No Abstract] [Full Text] [Related]
37. [Neutralizing antibodies against type 2 herpes simplex virus in women with cervicouterine cancer].
Ruiz-Gómez J; Gallegos Vargas G; Carranza García J; Alvarez y Muñoz MT
Ginecol Obstet Mex; 1977 Dec; 42(254):369-75. PubMed ID: 233828
[No Abstract] [Full Text] [Related]
38. Antibodies to Herpesvirus hominis types 1 and 2 in humans. II. Women with cervical cancer.
Nahmias AJ; Josey WE; Naib ZM; Luce CF; Guest BA
Am J Epidemiol; 1970 Jun; 91(6):547-52. PubMed ID: 4315624
[No Abstract] [Full Text] [Related]
39. Genital herpes virus findings in relation to cervical neoplasia.
Royston I; Aurelian L; Davis HJ
J Reprod Med; 1970 Apr; 4(4):9-13. PubMed ID: 4328889
[No Abstract] [Full Text] [Related]
40. A quantitative study of the infectious bovine rhinotracheitis neutralization test.
Mohanty SB; Lillie MG
Am J Vet Res; 1965 Jul; 26(113):892-6. PubMed ID: 4285515
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
